Business · 13/01/2017
FDA Releases Guidance on Nonproprietary Naming of Biological Products
The Food and Drug Administration (FDA) has released a guidance for industry on the naming of biological products, including originator products, related products, and biosimilar products, which will now include nonproprietary names with a core name and a four-letter suffix.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →